Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
The Journal of General Virology
|
January 1, 1981
Interferon production by human lymphoblastoid cell lines of different origins
G J Christofinis, C M Steel, N B Finter
Methods in Enzymology
|
January 1, 1981
Dye uptake method for assay of interferon activity
M D Johnston, N B Finter, P A Young
Developments in Biological Standardization
|
January 1, 1978
Effects of adverse storage on live virus vaccines
N B Finter, R Ferris, A Kelly, et al.
British Medical Journal (Clinical Research Ed.)
|
August 22, 1981
Toxicity of interferon
T J Priestman, R N Lucken, N B Finter
Advances in Experimental Medicine and Biology
|
January 1, 1978
Factors influencing production of interferon by human lymphoblastoid cells
M D Johnston, K H Fantes, N B Finter
Bioprocess Technology
|
January 1, 1990
Large-scale mammalian cell culture: a perspective
N B Finter, A J Garland, R C Telling
Developments in Biological Standardization
|
October 1, 1976
Long term storage studies with a new stabilised formulation of yellow fever virus vaccine
N B Finter, C Burfoot, P A Young, et al.
Journal of Interferon Research
|
September 1, 1989
Detection and incidence of neutralizing antibodies to interferon-alpha-n1
P K Weck, B G Leventhal, C Brand, et al.
Methods in Enzymology
|
January 1, 1986
Large-scale production of human interferon from lymphoblastoid cells
A W Phillips, N B Finter, C J Burman, et al.
The Journal of Infectious Diseases
|
June 1, 1976
Optimal schedules for use of interferon in the corneas of rabbits with herpes simplex keratitis
J I McGill, P Collins, K Cantell, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
The Journal of General Virology
|
January 1, 1981
Interferon production by human lymphoblastoid cell lines of different origins
G J Christofinis, C M Steel, N B Finter
Methods in Enzymology
|
January 1, 1981
Dye uptake method for assay of interferon activity
M D Johnston, N B Finter, P A Young
Developments in Biological Standardization
|
January 1, 1978
Effects of adverse storage on live virus vaccines
N B Finter, R Ferris, A Kelly, et al.
British Medical Journal (Clinical Research Ed.)
|
August 22, 1981
Toxicity of interferon
T J Priestman, R N Lucken, N B Finter
Advances in Experimental Medicine and Biology
|
January 1, 1978
Factors influencing production of interferon by human lymphoblastoid cells
M D Johnston, K H Fantes, N B Finter
Bioprocess Technology
|
January 1, 1990
Large-scale mammalian cell culture: a perspective
N B Finter, A J Garland, R C Telling
Developments in Biological Standardization
|
October 1, 1976
Long term storage studies with a new stabilised formulation of yellow fever virus vaccine
N B Finter, C Burfoot, P A Young, et al.
Journal of Interferon Research
|
September 1, 1989
Detection and incidence of neutralizing antibodies to interferon-alpha-n1
P K Weck, B G Leventhal, C Brand, et al.
Methods in Enzymology
|
January 1, 1986
Large-scale production of human interferon from lymphoblastoid cells
A W Phillips, N B Finter, C J Burman, et al.
The Journal of Infectious Diseases
|
June 1, 1976
Optimal schedules for use of interferon in the corneas of rabbits with herpes simplex keratitis
J I McGill, P Collins, K Cantell, et al.
Page
of 4